So, why are you telling me all this? These things I already know. Again my point to relaying this to Amarin is to inform them of a possible patent they could get priority on. Indications which already have studies on the drug you own are low hanging fruit. Don't let the competition snag an IP that you should get the first crack at.
News 
Market Data 
Discover 
